MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Cantharis vesicatoria 30c homeopathic tablets (Weleda (UK) Ltd)

Explore other Homeopathic cantharis vesicatoria formulations Explore other Cantharis vesicatoria 30c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Cantharis vesicatoria 6c homeopathic tablets (Special Order)

Explore other Homeopathic cantharis vesicatoria formulations Explore other Cantharis vesicatoria 6c homeopathic tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Cantharone 0.7% collodion (Imported (Canada))

Explore other Cantharidin formulations Explore other Cantharidin 0.7% collodion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Cantil 25mg tablets (Imported (United States))

Explore other Mepenzolate bromide formulations Explore other Mepenzolate bromide 25mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Capecitabine 150mg tablets (Accord-UK Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 150mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 150mg tablets (Amarox Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 150mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 150mg tablets (Dr Reddy's Laboratories (UK) Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 150mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 150mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 150mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 300mg tablets (Accord-UK Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 300mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 500mg tablets (Accord-UK Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 500mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 500mg tablets (Amarox Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 500mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 500mg tablets (Dr Reddy's Laboratories (UK) Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 500mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Explore other Capecitabine formulations Explore other Capecitabine 500mg tablets suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Capimune 100mg capsules (Viatris UK Healthcare Ltd)

Explore other Ciclosporin formulations Explore other Ciclosporin 100mg capsules suppliers

Stability Notes

Soft capsules. Keep in original packaging.

Provenance

This compatibility recommendation is derived from Deximune 100mg capsules (Dexcel-Pharma Ltd) and Neoral 100mg capsules (Novartis Pharmaceuticals UK Ltd).

Incompatible

Capimune 25mg capsules (Viatris UK Healthcare Ltd)

Explore other Ciclosporin formulations Explore other Ciclosporin 25mg capsules suppliers

Stability Notes

Soft capsules. Keep in original packaging.

Provenance

This compatibility recommendation is derived from Deximune 25mg capsules (Dexcel-Pharma Ltd) and Neoral 25mg capsules (Novartis Pharmaceuticals UK Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.